545 related articles for article (PubMed ID: 25673718)
21. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
22. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
Zhou B; Yang K; Wills E; Tang L; Baines JD
J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
[TBL] [Abstract][Full Text] [Related]
23. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
24. Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.
Zahn KE; Tchesnokov EP; Götte M; Doublié S
J Biol Chem; 2011 Jul; 286(28):25246-55. PubMed ID: 21566148
[TBL] [Abstract][Full Text] [Related]
25. Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene.
Chou S
Antiviral Res; 2017 Feb; 138():57-60. PubMed ID: 27940027
[TBL] [Abstract][Full Text] [Related]
26. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
27. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
[TBL] [Abstract][Full Text] [Related]
29. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Hwang YT; Zuccola HJ; Lu Q; Hwang CB
J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
[TBL] [Abstract][Full Text] [Related]
30. Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase.
Mousavi-Jazi M; Schloss L; Wahren B; Brytting M
J Clin Virol; 2003 Apr; 26(3):301-6. PubMed ID: 12637079
[TBL] [Abstract][Full Text] [Related]
31. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
[TBL] [Abstract][Full Text] [Related]
32. Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
Vashishtha AK; Kuchta RD
Biochemistry; 2016 Feb; 55(7):1168-77. PubMed ID: 26836009
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.
Chou S
J Clin Virol; 2011 Apr; 50(4):287-91. PubMed ID: 21295516
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic characterisation of cytomegalovirus DNA polymerase: a method to study cytomegalovirus isolates resistant to foscarnet.
Ducancelle A; Gravisse J; Alain S; Fillet AM; Petit F; Pors MJ; Mazeron MC
J Virol Methods; 2005 May; 125(2):145-51. PubMed ID: 15794984
[TBL] [Abstract][Full Text] [Related]
35. Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.
Gilbert C; Azzi A; Goyette N; Lin SX; Boivin G
Antimicrob Agents Chemother; 2011 Sep; 55(9):4019-27. PubMed ID: 21709106
[TBL] [Abstract][Full Text] [Related]
36. Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
Zarrouk K; Pham VD; Piret J; Shi R; Boivin G
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015044
[TBL] [Abstract][Full Text] [Related]
37. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
39. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
[TBL] [Abstract][Full Text] [Related]
40. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
Gilbert C; Boivin G
Antimicrob Agents Chemother; 2005 Dec; 49(12):4860-6. PubMed ID: 16304146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
